|
Re: What if RRR MACE is significant at 90% confidence?
|
3
|
Resverlogix Corp.
|
Apr 23, 2018 06:55PM
|
|
Rationale and Design of Apabetalone BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 03:32PM
|
|
Re: Nice volume surge at the end....
|
3
|
Resverlogix Corp.
|
Jun 28, 2017 11:35AM
|
|
Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
|
3
|
Zenith Epigenetics
|
Jan 07, 2020 09:11AM
|
|
Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
|
3
|
Zenith Epigenetics
|
Sep 12, 2018 06:03PM
|
|
Re: Playing with Number of patient years and RRR%
|
3
|
Resverlogix Corp.
|
Apr 01, 2019 11:24AM
|
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 12:36PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 08:22AM
|
|
Re: The countdown to 250
|
3
|
Resverlogix Corp.
|
Oct 12, 2018 11:41AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
3
|
Resverlogix Corp.
|
Nov 29, 2018 11:01AM
|
|
Re: Hide the Ball
|
3
|
Resverlogix Corp.
|
Jun 09, 2016 10:48AM
|
|
BET inhibitors act synergistically with PARP inhibitors
|
3
|
Zenith Epigenetics
|
Jul 27, 2017 10:27AM
|
|
Re: First presentation of BETonMACE data at ESC 2019?
|
3
|
Resverlogix Corp.
|
Apr 30, 2019 01:46PM
|
|
Zenith Notice of Meeting and Management Information Circular
|
3
|
Resverlogix Corp.
|
Dec 04, 2015 01:16PM
|
|
Re: If there is to be an amendment to the loan they don't have a lot of time....
|
3
|
Resverlogix Corp.
|
Jul 06, 2017 07:53AM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 03:54PM
|
|
Re: Position Sizing and Odds of Success
|
3
|
Resverlogix Corp.
|
Apr 26, 2019 01:04PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 04:03PM
|
|
Re: Update
|
3
|
Resverlogix Corp.
|
Feb 16, 2018 02:46PM
|
|
Re: Third Eye Loan
|
3
|
Resverlogix Corp.
|
Dec 28, 2018 11:16AM
|
